CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration

Cell Cycle

Volumn 13, Issue 6, 2014, Pages 974-983

  Li, Dengwen ^a   Gao, Jinmin ^a   Yang, Yunfan ^a   Sun, Lei ^b   Suo, Shaojun ^a   Luo, Youguang ^a   Shui, Wenqing ^a   Zhou, Jun ^a   Liu, Min ^b  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Centrosome; CYLD; EB1; Microtubule; Yeast two hybrid

Indexed keywords

BINDING PROTEIN; CYLINDROMATOSIS PROTEIN; DEUBIQUITINASE; END BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL MIGRATION; CELL STIMULATION; CENTROSOME; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE STABILIZATION; MICROTUBULE; MICROTUBULE ASSEMBLY; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TWO HYBRID SYSTEM; YEAST CELL;

CELL MIGRATION; CENTROSOME; CYLD; EB1; MICROTUBULE; YEAST-TWO HYBRID;

CELL MOVEMENT; CENTROSOME; HELA CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; TUMOR SUPPRESSOR PROTEINS;

EID: 84897968714     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.27838     Document Type: Article

References (37)

1. Kaverina I, Straube A. Regulation of cell migration by dynamic microtubules. Semin Cell Dev Biol 2011; 22:968-74; PMID:22001384; http://dx.doi.org/10.1016/j.semcdb.2011.09.017
2. Rodriguez OC, Schaefer AW, Mandato CA, Forscher P, Bement WM, Waterman-Storer CM. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 2003; 5:599-609; PMID:12833063; http://dx.doi.org/10.1038/ncb0703-599
3. Watanabe T, Noritake J, Kaibuchi K. Regulation of microtubules in cell migration. Trends Cell Biol 2005; 15:76-83; PMID:15695094; http://dx.doi.org/10. 1016/j.tcb.2004.12.006
4. Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 1997; 13:83-117; PMID:9442869; http://dx.doi.org/10.1146/annurev. cellbio.13.1.83
5. Joshi HC. Microtubule dynamics in living cells. Curr Opin Cell Biol 1998; 10:35-44; PMID:9484593; http://dx.doi.org/10.1016/S0955-0674(98)80084-7
6. Amos LA, Schlieper D. Microtubules and maps. Adv Protein Chem 2005; 71:257-98; PMID:16230114; http://dx.doi.org/10.1016/S0065-3233(04)71007-4
7. Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell Dev Biol 2000; 16:89-111; PMID:11031231; http://dx.doi.org/10.1146/annurev.cellbio.16.1.89
8. Galjart N. Plus-end-tracking proteins and their interactions at microtubule ends. Curr Biol 2010; 20:R528-37; PMID:20620909; http://dx.doi.org/10.1016/j.cub.2010.05.022
9. Jiang K, Akhmanova A. Microtubule tip-interacting proteins: a view from both ends. Curr Opin Cell Biol 2011; 23:94-101; PMID:20817499; http://dx.doi.org/10.1016/j.ceb.2010.08.008
10. Ligon LA, Shelly SS, Tokito MK, Holzbaur EL. Microtubule binding proteins CLIP-170, EB1, and p150Glued form distinct plus-end complexes. FEBS Lett 2006; 580:1327-32; PMID:16455083; http://dx.doi.org/10.1016/j.febslet.2006.01.050
11. Gao J, Huo L, Sun X, Liu M, Li D, Dong JT, Zhou J. The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration. J Biol Chem 2008; 283:8802-9; PMID:18222923; http://dx.doi.org/10.1074/jbc.M708470200
12. Sun SC. CYLD: a tumor suppressor deubiquitinase regulating NFkappaB activation and diverse biological processes. Cell Death Differ 2010; 17:25-34; PMID:19373246; http://dx.doi.org/10.1038/cdd.2009.43
13. Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci 2010; 35:392-9; PMID:20347313; http://dx.doi.org/10.1016/j.tibs.2010.02.007
14. Wickström SA, Masoumi KC, Khochbin S, Fässler R, Massoumi R. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin. EMBO J 2010; 29:131-44; PMID:19893491; http://dx.doi.org/10.1038/emboj.2009.317
15. Gao J, Sun L, Huo L, Liu M, Li D, Zhou J. CYLD regulates angiogenesis by mediating vascular endothelial cell migration. Blood 2010; 115:4130-7; PMID:20194890; http://dx.doi.org/10.1182/blood-2009-10-248526
16. Lohmann SM, Walter U, DeCamilli P. Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with tissue-specific binding proteins including microtubule-associated proteins. Ann N Y Acad Sci 1986; 466:449-52; PMID:3460424; http://dx.doi.org/10.1111/j.1749-6632.1986.tb38421.x
17. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NFkappaB. Nature 2003; 424:797-801; PMID:12917690; http://dx.doi.org/10.1038/nature01811
18. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NFkappaB signalling by deubiquitination. Nature 2003; 424:801-5; PMID:12917691; http://dx.doi.org/ 10.1038/nature01802
19. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NFkappaB activation by TNFR family members. Nature 2003; 424:793-6; PMID:12917689; http://dx.doi.org/10.1038/nature01803
20. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fässler R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NFkappaB signaling. Cell 2006; 125:665-77; PMID:16713561; http://dx.doi.org/10.1016/j. cell.2006.03.041
21. Vaughan KT. TIP maker and TIP marker; EB1 as a master controller of microtubule plus ends. J Cell Biol 2005; 171:197-200; PMID:16247021; http://dx.doi.org/10.1083/jcb.200509150
22. Peth A, Boettcher JP, Dubiel W. Ubiquitin-dependent proteolysis of the microtubule end-binding protein 1, EB1, is controlled by the COP9 signalosome: possible consequences for microtubule filament stability. J Mol Biol 2007; 368:550-63; PMID:17350042; http://dx.doi.org/10.1016/j.jmb.2007.02.052
23. Bornens M. Organelle positioning and cell polarity. Nat Rev Mol Cell Biol 2008; 9:874-86; PMID:18946476; http://dx.doi.org/10.1038/nrm2524
24. Cambray-Deakin MA, Burgoyne RD. Acetylated and detyrosinated alpha-tubulins are co-localized in stable microtubules in rat meningeal fibroblasts. Cell Motil Cytoskeleton 1987; 8:284-91; PMID:3319198; http://dx.doi.org/10.1002/cm.970080309
25. Honnappa S, Gouveia SM, Weisbrich A, Damberger FF, Bhavesh NS, Jawhari H, Grigoriev I, van Rijssel FJ, Buey RM, Lawera A, et al. An EB1-binding motif acts as a microtubule tip localization signal. Cell 2009; 138:366-76; PMID:19632184; http://dx.doi.org/10.1016/j.cell.2009.04.065
26. Steinmetz MO, Akhmanova A. Capturing protein tails by CAP-Gly domains. Trends Biochem Sci 2008; 33:535-45; PMID:18835717; http://dx.doi.org/10.1016/j. tibs.2008.08.006
27. Komander D, Lord CJ, Scheel H, Swift S, Hofmann K, Ashworth A, Barford D. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 2008; 29:451-64; PMID:18313383; http://dx.doi.org/10.1016/j.molcel.2007.12.018
28. Kampinga HH, Craig EA. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 2010; 11:579-92; PMID:20651708; http://dx.doi.org/10.1038/nrm2941
29. Gutmann DA, Ward A, Urbatsch IL, Chang G, van Veen HW. Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. Trends Biochem Sci 2010; 35:36-42; PMID:19819701; http://dx.doi.org/10.1016/j. tibs.2009.07.009
30. Zhang Z, Wu JY, Hait WN, Yang JM. Regulation of the stability of P-glycoprotein by ubiquitination. Mol Pharmacol 2004; 66:395-403; PMID:15322230; http://dx.doi.org/10.1124/mol.104.001966
31. Korsse SE, Peppelenbosch MP, van Veelen W. Targeting LKB1 signaling in cancer. Biochim Biophys Acta 2013; 1835:194-210; PMID:23287572
32. Nakano A, Takashima S. LKB1 and AMP-activated protein kinase: regulators of cell polarity. Genes Cells 2012; 17:737-47; PMID:22892070; http://dx.doi.org/10.1111/j.1365-2443.2012.01629.x
33. Mian I, Pierre-Louis WS, Dole N, Gilberti RM, Dodge-Kafka K, Tirnauer JS. LKB1 destabilizes microtubules in myoblasts and contributes to myoblast differentiation. PLoS One 2012; 7:e31583; PMID:22348111; http://dx.doi.org/10. 1371/journal.pone.0031583
34. Dong X, Liu F, Sun L, Liu M, Li D, Su D, Zhu Z, Dong JT, Fu L, Zhou J. Oncogenic function of microtubule end-binding protein 1 in breast cancer. J Pathol 2010; 220:361-9; PMID:19967727
35. Sun L, Gao J, Dong X, Liu M, Li D, Shi X, Dong JT, Lu X, Liu C, Zhou J. EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A. Proc Natl Acad Sci USA 2008; 105:7153-8; PMID:18477699; http://dx.doi.org/10.1073/pnas.0710018105
36. Yang Y, Sun L, Tala, Gao J, Li D, Zhou J, Liu M. CYLD regulates RhoA activity by modulating LARG ubiquitination. PLoS One 2013; 8:e55833; PMID:23405219; http://dx.doi.org/10.1371/journal.pone.0055833
37. Sun L, Gao J, Huo L, Sun X, Shi X, Liu M, Li D, Zhang C, Zhou J. Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B. J Pathol 2010; 221:425-32; PMID:20593489